Dr. Kelly A. Cawcutt, MD

Dr. Cawcutt practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Cawcutt's NPI, 1982868436, was assigned on July 14, 2008. Dr. Cawcutt graduated from University of Minnesota Medical School in 2008. Dr. Cawcutt holds Nebraska license 28989.

Dr. Cawcutt's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Cawcutt also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Cawcutt's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Cawcutt is also affiliated with Mary Lanning Healthcare. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Cawcutt to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cawcutt practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Cawcutt's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Cawcutt's licenses on file in 2 states: Nebraska and Minnesota.

CMS data shows 134 Medicare services from Dr. Cawcutt across 2 procedure codes in 2024, for 67 Medicare patients. Medicare paid $11,574 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Cawcutt in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cawcutt's median patient age at 62, with 49% women.

In 2024, Dr. Cawcutt wrote 52 Medicare Part D claims for 11 patients. 85% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $3,339 in total drug cost.

Dr. Cawcutt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cawcutt as offering telehealth.

Dmand AI links 70 papers to Dr. Cawcutt, published from 2012 to 2025. 2021 was the busiest year, with 8. The most frequent topics are COVID-19, Intensive Care Units and Cross Infection. Dr. Cawcutt has published most often in Infect Control Hosp Epidemiol. Dr. Cawcutt's most frequent co-authors are Andre C. Kalil, MD, Jasmine R. Marcelin, MD and Richard Jordan Hankins, MD.

CMS Open Payments shows 3 general payments to Dr. Cawcutt from 2 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 89% of the total. Becton, Dickinson and Company paid the most, $2,150.

Dr. Cawcutt graduated from University of Minnesota Medical School in 2008.